A $28.5 million commercialisation boost will soon be available to MedTechs fighting heart disease and diabetes under the latest round of a Medical Research Future Fund program. The second round of the Targeted Translation Research Accelerator (TTRA), which focuses on commercialising novel therapeutics and devices for diabetes and cardiovascular disease, will be run by former…

The post MTPConnect secures $28.5m for MedTech accelerator appeared first on InnovationAus.com.